Market News

Latest financial and economic news and analysis

Seeking Alpha News Agency
5 days ago•Seeking Alpha
Stocks Medium Importance Neutral
Bed Bath & Beyond: An Unprecedented, Unfocused Plan

Bed Bath & Beyond: An Unprecedented, Unfocused Plan

Bed Bath & Beyond, soon Neighborhood Intelligence, is a qualitative turnaround bet centered on CEO Marcus Lemonis's ambitious multi-pillar strategy. Lemonis envisions a synergistic ecosystem spanning retail, financial, and home services, but customer retention and cross-sell logic remain unproven and historically fraught. The investment case is highly speculative; the grand strategy and basic turnaround both face daunting execution risks with little evidence of early traction.

Related Symbols 1
BBBY BBBY
Source: Seeking Alpha
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Seeking Alpha News Agency
5 days ago•Seeking Alpha
Stocks Medium Importance Neutral
Dine Brands Global Is Cheap, But The Long-Term Picture Isn't Worth Banking On Yet

Dine Brands Global Is Cheap, But The Long-Term Picture Isn't Worth Banking On Yet

Dine Brands Global reported Q2 2026 revenue above expectations, but EPS and adjusted EPS missed analyst estimates. While DIN remains objectively cheap on both absolute and relative valuation, persistent declines in profitability and rising net debt temper enthusiasm. Growth in IHOP system-wide sales and dual-branded locations offers long-term opportunity, but near-term cash flow and margin pressures persist.

Related Symbols 1
GTLL GTLL
Source: Seeking Alpha
Visit Source
0 0 0
Read More
Comment
GlobeNewsWire News Agency
5 days ago•GlobeNewsWire
Stocks Medium Importance Neutral
Hagens Berman Sobol Shapiro LLP Notifies Shareholders of Photronics, Inc. (PLAB) of a Securities Class Action Lawsuit and the Opportunity to Seek a Lead Plaintiff Position

Hagens Berman Sobol Shapiro LLP Notifies Shareholders of Photronics, Inc. (PLAB) of a Securities Class Action Lawsuit and the Opportunity to Seek a Lead Plaintiff Position

SAN FRANCISCO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Hagens Berman, a leading national shareholder rights law firm, is conducting an investigation into Photronics, Inc. (NASDAQ: PLAB) regarding alleged violations of federal securities laws. This investigation follows the recent filing of a class action lawsuit, which alleges that Photronics misled investors concerning the demand and outlook for its high-end integrated circuit (IC) photomask product line.

Related Symbols 1
PLAB PLAB
Source: GlobeNewsWire
Visit Source
0 0 0
Read More
Comment
GlobeNewsWire News Agency
5 days ago•GlobeNewsWire
Stocks Medium Importance Neutral
Black Rock Coffee Bar, Inc. (BRCB) Faces Securities Class Action Related to IPO Disclosures Regarding Adverse Impact of Sales Transfer Phenomenon – Hagens Berman

Black Rock Coffee Bar, Inc. (BRCB) Faces Securities Class Action Related to IPO Disclosures Regarding Adverse Impact of Sales Transfer Phenomenon – Hagens Berman

SAN FRANCISCO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman is actively investigating claims in a pending securities class action alleging securities law violations at Black Rock Coffee Bar, Inc. (NASDAQ: BRCB). The suit alleges the company and its senior executives provided false and misleading information to investors regarding the efficacy of its expansion strategy during its September 2025 Initial Public Offering (IPO) and throughout the subsequent months.

Related Symbols 1
JVA JVA
Source: GlobeNewsWire
Visit Source
0 0 0
Read More
Comment
GlobeNewsWire News Agency
5 days ago•GlobeNewsWire
Stocks Medium Importance Neutral
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP

SAN FRANCISCO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed after repeated surprise unit handpiece sales underperformance and gradual revelations of excess customer inventory levels driven by repeated, late-quarter, bulk discounts. The lawsuit seeks to represent investors who purchased or otherwise acquired PROCEPT common stock between February 28, 2024 and February 25, 2026.

Related Symbols 1
PRCT PRCT
Source: GlobeNewsWire
Visit Source
0 0 0
Read More
Comment
24/7 Wall Street News Agency
5 days ago•24/7 Wall Street
Stocks Medium Importance Neutral
From $100 to $2,021 in Five Years: How Daily-Reset Leverage Turns Trends Into Fortunes

From $100 to $2,021 in Five Years: How Daily-Reset Leverage Turns Trends Into Fortunes

Here is the number that should stop any leveraged ETF trader in their tracks: year to date through Tuesday's close, the GraniteShares 2x Long NVDA Daily ETF (NASDAQ:NVDL) is up 11.5%.

Related Symbols 1
NVDL NVDL
Source: 24/7 Wall Street
Visit Source
0 0 0
Read More
Comment
Newsfile Corp News Agency
5 days ago•Newsfile Corp
Stocks Medium Importance Neutral
Kingman Adopts Semi-Annual Financial Reporting

Kingman Adopts Semi-Annual Financial Reporting

Vancouver, British Columbia--(Newsfile Corp. - August 5, 2026) - Kingman Minerals Ltd. (TSXV: KGS) (OTCQB: KGSSF) (FSE: 47A1) ("Kingman" or the "Company") announces that its Board of Directors has approved the Company's election to rely on Coordinated Blanket Order 51-933 - Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (the "Blanket Order") issued by the Canadian Securities Administrators ("CSA").

Related Symbols 1
KGS KGS
Source: Newsfile Corp
Visit Source
0 0 0
Read More
Comment
Accesswire News Agency
5 days ago•Accesswire
Stocks Medium Importance Neutral
Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

mFLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved product Company expects supply to be available in select retailers in the coming weeks CAMBRIDGE, MA / ACCESS Newswire / August 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mFLUSIVA® (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older. This approval follows unanimous recommendations from the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) supporting mFLUSIVA for adults 50 years of age and older.

Related Symbols 1
MRNA MRNA
Source: Accesswire
Visit Source
0 0 0
Read More
Comment
Reuters News Agency
5 days ago•Reuters
Stocks Medium Importance Neutral
Australia's Beach Energy swings to annual profit, shares slide on weak production outlook

Australia's Beach Energy swings to annual profit, shares slide on weak production outlook

Beach Energy posted an annual profit on Thursday, a sharp turnaround from a year-earlier loss, although ​shares of the Australian oil and gas producer slipped more than 6% as ‌investors focused on its soft production outlook.

Related Symbols 1
BCHEY BCHEY
Source: Reuters
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Seeking Alpha News Agency
5 days ago•Seeking Alpha
Stocks Medium Importance Neutral
Rigel Pharmaceuticals: A Four-Drug Company With A Clinical Catalyst Ahead

Rigel Pharmaceuticals: A Four-Drug Company With A Clinical Catalyst Ahead

Rigel Pharmaceuticals in-licensed Veppanu, a drug for the treatment of certain breast cancer patients, targeting a $1B market, with revenues expected as early as Q3'26. Q2'26 saw strong sales growth from Tavalisse and Rezlidhia, offsetting Gavreto's middling performance. RIGL guides $285M–$295M 2026 revenues, excluding Veppanu upside. Upcoming R289 phase 1b data for LR-MDS and future readouts from Veppanu and Rezlidhia trials provide additional growth catalysts.

Related Symbols 1
RIGL RIGL
Source: Seeking Alpha
Visit Source
0 0 0
Read More
Comment